all AI news
Lantern Pharma expands AI capabilities of RADR® Platform
AI – AI-TechPark ai-techpark.com
Expansion of RADR® platform adds new AI capabilities for the automated identification of new and effective combination therapy regimens for immune checkpoint inhibitors (ICI) Additional functionality includes the creation and testing of molecular signatures of ICI response and resistance with a highly scalable, machine-learning based system designed to improve ICI clinical...
The post Lantern Pharma expands AI capabilities of RADR® Platform first appeared on AI-TechPark.
ai ai capabilities automated capabilities combination expansion identification machine pharma platform scalable testing therapy